The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

AlzheimerNews

News A new large trial in Alzheimer’s disease Published in May 2018 in the NEJM

Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer’s disease. Authors  conducted a randomized, double-blind, placebo-controlled, 78-week trial to evaluate verubecestat at doses of 12 mg and 40 mg per… Continue Reading →

Research & Science Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A report from the EU/US/CTAD Task Force

 Just published in the JPAD (Journ Prev Alz disease www.jpreventionalzheimer.com) Agitation and other neuropsychiatric symptoms (NPS) are the most disruptive aspects of dementia for both patients and caregivers. They are associated with worse quality of life, greater dementia severity, earlier… Continue Reading →

Diabetes Mellitus and Cognitive Decline – Prevention Should not be Delayed!

This is a restricted content for our subscribers.

© 2018 Aging-news — Powered by WordPress

Theme inspired by Anders NorenUp ↑